Reason for request
Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals.
Clinical Benefit
| Insufficient |
The actual benefit of LERCAPRESS 10 mg/10 mg is insufficient in view of the available clinical data: this data is insufficient to assess its value for the management of hypertensive patients. |
| Substantial |
|
Clinical Added Value
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
xjqmu2zUhcvYx9Fp
Listen
